Home

Search Abstracts

Browse Sessions

Program Committee

Conference Webcasts

Contact Us

---

Session 131   Poster Abstracts Natural History of HIV-1 and Antiretroviral Treatment Response in Women Monday, 1:30 - 3:30 pm Poster Hall

949	Clinical, Virological, and Immunological Outcomes of Female Patients Treated with HAART for 48 Months L Sarmati*1, L Palmisano2, C Angeletti3, A Chiesi2, E Nicastri3, A Geraci2, S Vella2, M Andreoni1, and and the Italian Antiretroviral Treatment Group (IATG) 1Univ. of Rome Tor Vergata, Italy; 2Inst. Superiore di Sanità, Rome, Italy; and 3Natl. Inst. of Infectious Diseases, IRCCS L. Spallanzani, Rome
950	Predictors of CD4 Decline in Women with Incident HIV-1 Infection in East and Southern Africa C Morrison*1, C Kwok1, K Demers2, A Lovvorn1, T Chipato3, F Mmiro4, R Mugerwa4, N Padian5, P Chen1, P Cornelisse6, E Arts2, and R Salata2 1Family Hlth. Intl., Research Triangle Park, NC, USA; 2Case Western Reserve Univ., Cleveland, OH, USA; 3Univ. of Zimbabwe, Harare; 4Makerere Univ, Kampala, Uganda; 5Univ. of California, San Francisco, USA; and 6Fred Hutchinson Cancer Res. Ctr., Seattle, WA, USA
951	AIDS-defining Illnesses Develop with Lower CD4 Cell Counts and Higher Plasma HIV RNA Levels in HIV-infected Women than in Men M Lisgaris*1,2, B Rodriguez1,2, G Yadavalli3, R Salata1,2, B Gripshover1,2, G McComsey1,2, S Fulton1,2, and M Lederman1,2 1Case Western Reserve Univ., Cleveland, OH, USA; 2Univ. Hospitals of Cleveland, OH, USA; and 3VA Med. Ctr., Cleveland, OH, USA
952	A History of Injection Drug Use among Women Is Associated with Increased Diversity in the HIV-1 Protease Gene M-F Yeh*1, J Kowalski2, Q Shao1, G Zhang1, S Gange1, M Schneider1, and R Markham1 1Johns Hopkins Bloomberg Sch. of Publ. Hlth., Baltimore, MD, USA and 2Johns Hopkins Sch. of Med., Baltimore, MD, USA